BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 408278)

  • 1. Differential sensitivity of Xeroderma pigmentosum cells of different repair capacities towards the chromosome breaking action of carcinogens and mutagens.
    San RH; Stich W; Stich HF
    Int J Cancer; 1977 Aug; 20(2):181-7. PubMed ID: 408278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of DNA damage after exposure to 4-nitroquinoline-1-oxide in heterokaryons derived from xeroderma pigmentosum cells.
    Zelle B; Bootsma D
    Mutat Res; 1980 May; 70(3):373-81. PubMed ID: 6770261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response to DNA damage induced by 4-nitroquinoline-1-oxide or its 3-methyl derivative in xeroderma pigmentosum fibroblasts belonging to different complementation groups: evidence for different epistasis groups involved in the repair of large adducts in human DNA.
    Edwards S; Fielding S; Waters R
    Carcinogenesis; 1987 Aug; 8(8):1071-5. PubMed ID: 3111741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations among species and cell types in the effects of caffeine on mutagen-induced cytotoxicity and postreplication repair of DNA.
    Sivak A; Rudenko L; Teague LG
    Environ Mutagen; 1982; 4(2):143-62. PubMed ID: 6804226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Number of chromosome aberrations induced by chemical carcinogens in the cells of patients with 2 forms of xeroderma pigmentosum].
    Khachapuridze GG; Mikhel'son VM; Zhestianikov VD
    Tsitologiia; 1980 Mar; 22(3):343-9. PubMed ID: 6768181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sister chromatid exchanges induced by mutagenic carcinogens in normal and xeroderma pigmentosum cells.
    Wolff S; Rodin B; Cleaver JE
    Nature; 1977 Jan; 265(5592):347-9. PubMed ID: 834283
    [No Abstract]   [Full Text] [Related]  

  • 7. The sensitivity of human fibroblasts to N-acetoxy-2-acetylaminofluorene is determined by the extent of transcription-coupled repair, and/or their capability to counteract RNA synthesis inhibition.
    van Oosterwijk MF; Filon R; Kalle WH; Mullenders LH; van Zeeland AA
    Nucleic Acids Res; 1996 Dec; 24(23):4653-9. PubMed ID: 8972850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair in human fibroblasts treated with a combination of chemicals.
    Ahmed FE; Setlow RB
    Biophys J; 1981 Jul; 35(1):17-22. PubMed ID: 6789902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in levels of 5'-adenyl dinucleotides following DNA damage in normal human fibroblasts and fibroblasts derived from patients with xeroderma pigmentosum.
    Baker JC; Ames BN
    Mutat Res; 1988 Jun; 208(2):87-93. PubMed ID: 2454402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of homozygous and heterozygous xeroderma pigmentosum cells to several chemical and viral carcinogens.
    Stich HF
    Basic Life Sci; 1975; 5B():773-84. PubMed ID: 1103877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of carcinogenic aromatic amides in normal and xeroderma pigmentosum fibroblasts with different DNA repair capabilities.
    Maher VM; Birch N; Otto JR; MacCormick JJ
    J Natl Cancer Inst; 1975 Jun; 54(6):1287-94. PubMed ID: 1133846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined action of chemical carcinogens on DNA repair in human cells.
    Ahmed FE
    Radiat Environ Biophys; 1980; 18(1):57-64. PubMed ID: 6777821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and 4-nitroquinoline 1-oxide-induced G2 chromosome aberrations in lymphoblasts from familial melanoma patients.
    Lu GH; Hayward NK; Stanley WS
    Cancer Genet Cytogenet; 1989 Jun; 39(2):233-43. PubMed ID: 2502307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and its repair in human normal or xeroderma pigmentosum fibroblasts treated with 4-nitroquinoline 1-oxide or its 3-methyl derivative.
    Mirzayans R; Waters R
    Carcinogenesis; 1981; 2(12):1359-62. PubMed ID: 6799219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unscheduled DNA synthesis induced by 4-nitroquinoline-1-oxide in xeroderma pigmentosum cells and their complementing heterodikaryons.
    Tanaka K; Takebe H; Okada Y
    Somatic Cell Genet; 1980 Nov; 6(6):739-49. PubMed ID: 6777887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations in xeroderma pigmentosum cells exposed to the carcinogens, 4-nitroquinoline-1-oxide and N-methyl-N'-nitrosoguanidine.
    Stich HF; Stich W; San RH
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1141-4. PubMed ID: 4694815
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA excision in repair proficient and deficient human cells treated with a combination of ultraviolet radiation and acridine mustard (ICR-170) or 4-nitroquinoline 1-oxide.
    Ahmed FE; Setlow RB
    Chem Biol Interact; 1980 Jan; 29(1):31-42. PubMed ID: 6153160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced DNA repair capacity and increased cytotoxicity following split doses of the mutagen 4-nitroquinoline-1-oxide in cultured human cells.
    Warren PM; Stich HF
    Mutat Res; 1975 May; 28(2):285-93. PubMed ID: 806012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline sucrose sedimentation analysis as an indicator of repair capability of xeroderma pigmentosum fibroblasts for 4-nitroquinoline-1-oxide damage.
    Walker IG
    Carcinogenesis; 1981; 2(8):691-5. PubMed ID: 6793257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.